BASELINE LEUKOCYTE AND EOSINOPHIL COUNTS PREDICT OUTCOME IN RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA PATIENTS TREATED WITH PD1 INHIBITION

被引：0
|
作者：
Hude, I. [1 ,2 ]
Sasse, S. [2 ]
Broeckelmann, P. J. [2 ]
von Tresckow, B. [2 ]
Momotow, J. [2 ]
Engert, A. [2 ]
Borchmann, S. [2 ]
机构：
[1] Univ Hosp Ctr Zagreb, Div Hematol, Dept Internal Med, Zagreb, Croatia
[2] Univ Hosp Cologne, Dept Internal Med 1, GHSG, Cologne, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1119
引用
收藏
页码：460 / 460
页数：1
相关论文
共 50 条
  • [21] Dominant negative PD1 armored CAR-T cells induce remission in relapsed or refractory non-Hodgkin lymphoma (NHL) patients
    Yuan, Yan
    Huang, Liansheng
    Su, Yang
    Pu, Chengfei
    Ding, Tianling
    Xiao, Xibin
    Jin, Lina
    Cao, Zhiyuan
    Wu, Ting
    Chen, Tong
    Ding, Luying
    Zhang, Xiaohong
    Lan, Haifeng
    Wu, Zhao
    Xiao, Lei
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Outcomes Following Combined Radiotherapy with Brentuximab Vedotin or PD-1 Inhibitors in Relapsed/refractory Classical Hodgkin Lymphoma
    Plastaras, John
    Maxwell, Russell
    Man-Junath, Shwetha
    Twerski, Meshulam
    Carpenter, Maribel
    LaRiviere, Michael
    Paydar, Ima
    Chong, Elise
    Landsburg, Daniel
    Svoboda, Jakub
    Nasta, Sunita
    Schuster, Stephen
    Maity, Amit
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S14 - S14
  • [23] Exposure–response analysis of Camidanlumab tesirine in patients with relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma
    Marie Toukam
    Joseph P. Boni
    Mehdi Hamadani
    Paolo F. Caimi
    Hans G. Cruz
    Jens Wuerthner
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 1 - 12
  • [24] Efficacy of Haploidentical Stem Cell Transplantation for Patients with Relapsed/refractory Classical Hodgkin Lymphoma
    Beynarovich, Anastasiya
    Lepik, Kirill
    Mikhailova, Natalia
    Kondakova, Elena
    Zalyalov, Yurii
    Borzenkova, Eugenia
    Babenko, Elena
    Darskaya, Elena
    Aliynskiy, Alexander
    Moiseev, Ivan
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 519 - 520
  • [25] Immune microenvironment in classical Hodgkin lymphoma: Composition and dynamics in patients with relapsed/refractory disease
    Fedorova, L.
    Gusak, A.
    Lepik, K.
    Volkov, N.
    Popova, M.
    Moiseev, I.
    Mikhailova, N.
    Baykov, V.
    Kulagin, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S776 - S776
  • [26] Gemcitabine plus rituximab therapy of patients with relapsed and refractory classical Hodgkin lymphoma.
    Younes, A
    Fayad, L
    Pro, B
    Goy, A
    Romaguera, JE
    Hagemeister, FB
    McLaughlin, P
    BLOOD, 2005, 106 (11) : 431A - 431A
  • [27] Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America
    Gossen, Seisha Alana Von Glasenapp
    Martinez-Cordero, Humberto
    Villela, Luis
    Rocio Colunga-Pedraza, Perla
    Perez-Jacobo, Fernando
    Robles, Arianna
    Garces Paz, Diego Fernando
    Idrobo, Henry
    Castro, Denisse
    Rose Paredes, Sally
    Beltran, Brady E.
    Oliver, Ana Carolina
    Irigoin, Victoria
    Alejandro Ospina, Juan
    Oliday Rios, Rosa
    BLOOD, 2022, 140 : 9429 - 9430
  • [28] Lymphoma Associated Macrophages Predict Survival in Uniformly Treated Patients with Classical Hodgkin Lymphoma
    Farinha, P.
    Rodrigues, S.
    Fernandes, T.
    Monteiro, A.
    da Silva, R. Lopes
    Salvador, J.
    Gerivaz, R.
    Costa, F.
    Ferreira, G.
    Lopes, C.
    Lacerda, T.
    Ferreira, J.
    Costa, I.
    de Sousa, A. Botelho
    MODERN PATHOLOGY, 2011, 24 : 296A - 296A
  • [29] Lymphoma Associated Macrophages Predict Survival in Uniformly Treated Patients with Classical Hodgkin Lymphoma
    Farinha, P.
    Rodrigues, S.
    Fernandes, T.
    Monteiro, A.
    Lopes da Silva, R.
    Salvador, J.
    Gerivaz, R.
    Costa, F.
    Ferreira, G.
    Lopes, C.
    Lacerda, T.
    Ferreira, J.
    Costa, I.
    Botelho de Sousa, A.
    LABORATORY INVESTIGATION, 2011, 91 : 296A - 296A
  • [30] Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
    Sauer, Maike
    Pluetschow, Annette
    Jachimowicz, Ron D.
    Kleefisch, Dominik
    Reiners, Katrin S.
    Ponader, Sabine
    Engert, Andreas
    von Strandmann, Elke Pogge
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (02) : 113 - 115
12345